The reduced release of GH by GHRH in 8 subjects aged 65-69 years is augmented considerably by rivastigmine, a drug for Alzheimer's disease.

导出 LinkOut

翻译打印收藏纠错

作者： Rudolf P,Obermayr ^[1] ; Lothar,Mayerhofer ; Maarten,Knechtelsdorfer ; Karl H,Tragl ; Georg,Geyer

作者单位： 1st Medical Department, Donauspital im Sozialmedizinischen Zentrum Ost der Stadt Wien, and Ludwig Boltzmann Institute for Aging Research, Vienna, Austria. rudolf.obermayr@chello.at ^[1]

主题词老年人(Aged);阿尔茨海默病(Alzheimer Disease);氨甲酸酯类(Carbamates);胆碱酯酶抑制剂(Cholinesterase Inhibitors);女(雌)性(Female);生长激素(Growth Hormone);生长激素释放激素(Growth Hormone-Releasing Hormone);人类(Humans);男(雄)性(Male);苯氨基甲酸酯类(Phenylcarbamates)

DOI 10.1159/000069175

PMID 12679611

发布时间 2017-11-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Gerontology

191-5页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

The reduced release of GH by GHRH in 8 subjects aged 65-69 years is augmented considerably by rivastigmine, a drug for Alzheimer's disease.

Gerontology

相似文献

Gerontology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The reduced release of GH by GHRH in 8 subjects aged 65-69 years is augmented considerably by rivastigmine, a drug for Alzheimer's disease.

Gerontology

相似文献

Gerontology

相关期刊

检索历史清除